KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) Restructuring Costs (2016 - 2026)

Medtronic's Restructuring Costs history spans 14 years, with the latest figure at $77.0 million for Q1 2026.

  • On a quarterly basis, Restructuring Costs rose 79.07% to $77.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $282.0 million, a 35.17% decrease, with the full-year FY2025 number at $267.0 million, up 18.14% from a year prior.
  • Restructuring Costs hit $77.0 million in Q1 2026 for Medtronic, up from $13.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for MDT hit a ceiling of $300.0 million in Q2 2023 and a floor of $13.0 million in Q4 2025.
  • Historically, Restructuring Costs has averaged $93.2 million across 5 years, with a median of $62.0 million in 2024.
  • Biggest five-year swings in Restructuring Costs: skyrocketed 550.0% in 2023 and later tumbled 56.67% in 2025.
  • Tracing MDT's Restructuring Costs over 5 years: stood at $30.0 million in 2022, then soared by 33.33% to $40.0 million in 2023, then fell by 25.0% to $30.0 million in 2024, then tumbled by 56.67% to $13.0 million in 2025, then soared by 492.31% to $77.0 million in 2026.
  • Business Quant data shows Restructuring Costs for MDT at $77.0 million in Q1 2026, $13.0 million in Q4 2025, and $45.0 million in Q3 2025.